A Teratocarcinoma-Like Human Embryonic Stem Cell (hESC) Line and Four hESC Lines Reveal Potentially Oncogenic Genomic Changes

• Outi Hovatta ,

  * E-mail: Outi.hovatta@ki.se

  Affiliation Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Marisa Jaconi,

  Affiliation Department of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland

  ⨯
• Virpi Töhönen,

  Affiliation Department of Biosciences, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Frédérique Béna,

  Affiliation Department of Genetic Medicine and Development, University of Geneva Medical School and Geneva University Hospitals, Geneva, Switzerland

  ⨯
• Stefania Gimelli,

  Affiliation Department of Genetic Medicine and Development, University of Geneva Medical School and Geneva University Hospitals, Geneva, Switzerland

  ⨯
• Alexis Bosman,

  Affiliation Department of Pathology and Immunology, University of Geneva Medical School, Geneva, Switzerland

  ⨯
• Frida Holm,

  Affiliation Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Stefan Wyder,

  Affiliation Swiss Institute of Bioinformatics, Geneva, Switzerland

  ⨯
• Evgeny M. Zdobnov,

  Affiliation Swiss Institute of Bioinformatics, Geneva, Switzerland

  ⨯
• Olivier Irion,

  Affiliation Department of Obstetrics and Gynecology, Geneva University Hospitals, Geneva, Switzerland

  ⨯
• Peter W. Andrews,

  Affiliation Centre for Stem Cell Biology and Department of Biomedical Science, University of Sheffield, Sheffield, United Kingdom

  ⨯
• Stylianos E. Antonarakis,

  Affiliation Department of Genetic Medicine and Development, University of Geneva Medical School and Geneva University Hospitals, Geneva, Switzerland

  ⨯
• Marco Zucchelli,

  Affiliation Department of Biosciences, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Juha Kere ,

  Contributed equally to this work with: Juha Kere, Anis Feki

  Affiliation Department of Biosciences, Karolinska Institutet, Stockholm, Sweden

  ⨯
• Anis Feki

  Contributed equally to this work with: Juha Kere, Anis Feki

  Affiliation Department of Obstetrics and Gynecology, Geneva University Hospitals, Geneva, Switzerland

  ⨯